Human medicines European public assessment report (EPAR): Emtricitabine/Tenofovir disoproxil Mylan, emtricitabine,tenofovir disoproxil, Date of authorisation: 16/12/2016, Revision: 17, Status: Authorised

Human medicines European public assessment report (EPAR): Emtricitabine/Tenofovir disoproxil Mylan, emtricitabine,tenofovir disoproxil, Date of authorisation: 16/12/2016, Revision: 17, Status: Authorised

Quarterly System Demo - Q2 2025, Online, European Medicines Agency, Amsterdam, the Netherlands, Broadcast, from 26 June 2025, 09:00 (CEST) to 26 June 2025, 10:45 (CEST)

Quarterly System Demo - Q2 2025, Online, European Medicines Agency, Amsterdam, the Netherlands, Broadcast, from 26 June 2025, 09:00 (CEST) to 26 June 2025, 10:45 (CEST)

Newsletters

Stay informed on our latest news!

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

randomness